Drug Shortage Report for FOQUEST

Last updated on 2024-05-13 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-09-30
Actual end date
Shortage status Actual shortage
Updated date 2024-05-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v160 2024-05-13 French Compare
v159 2024-05-13 English Compare
v158 2024-05-13 English Compare
v157 2024-04-30 French Compare
v156 2024-04-30 English Compare
v155 2024-03-06 French Compare
v154 2024-03-06 English Compare
v153 2023-11-01 French Compare
v152 2023-11-01 English Compare
v151 2023-10-25 French Compare
v150 2023-10-25 English Compare
v149 2023-10-17 French Compare
v148 2023-10-17 English Compare
v147 2023-10-05 French Compare
v146 2023-10-05 English Compare
v145 2023-10-03 French Compare
v144 2023-10-03 English Compare
v143 2023-09-22 French Compare
v142 2023-09-22 English Compare
v141 2023-08-31 French Compare

Showing 1 to 20 of 160